Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 10 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
CURISPHAR from Deerlijk, company number BE0719758212, closed financial year 2025 with a result of € 202,193 after tax. For that financial year CURISPHAR recorded a gross margin of € 292,735 and equity of € 26,354. Compared with financial year 2024, the result moved from € 148,019 to € 202,193. Profitable, and profit is growing. The buffer shrank hard: equity is 95 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.
€ 26,354
▼ 95% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 202,193
▲ 37% vs 2024
Profit after tax over the fiscal year.
€ 44,834
▲ 95% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 658,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
€ 3,785
▼ 40% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 755,347
▼ 10% vs 2024
€ 80,833 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.
€ 3,536
▼ 18% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 11,466
▲ 17% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 28,216 | € 267,513 | € 228,636 | € 292,735 | ▲ 28% |
| Profit after taxes | € 2,394 | € 191,535 | € 148,019 | € 202,193 | ▲ 37% |
| Equity | € 145,992 | € 335,861 | € 482,161 | € 26,354 | ▼ 95% |
| Total debts | € 1,231,220 | € 1,243,188 | € 890,063 | € 1,362,681 | ▲ 53% |
| Cash | € 15,981 | € 69,933 | € 23,023 | € 44,834 | ▲ 95% |
| Retained profit | € 127,392 | € 317,261 | € 463,561 | € 7,754 | ▼ 98% |
| Dividend | € 1,600 | € 1,666 | € 1,718 | € 658,000 | ▲ € 656,282 |
| Bank debt | € 936,654 | € 911,964 | € 836,738 | € 755,347 | ▼ 10% |
| Balance sheet total | € 1,377,212 | € 1,579,049 | € 1,372,224 | € 1,389,035 | ▲ 1% |
Key figures of CURISPHAR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to CURISPHAR?
What happened at CURISPHAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 202,193 (▲ 37% vs 2024). Source: NBB ↗
- Tim Windels became a director. NBB
- New establishment in Deerlijk. KBO
- Charlotte Vandenbussche became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 2,394 profit in 2022 to € 202,193 profit in 2025.
Paid € 186,200 in corporate taxes since 2022.
Best year ever: 2025, with € 202,193 profit.
Paid out € 662,984 in dividends to the owners in total.
Management
Behind CURISPHAR are Tim Windels and Charlotte Vandenbussche. It owns 50% of Apotheek Vichte BV itself.
Directors
According to the 2025 annual accounts
Tim Windels
Director
since 2020
Charlotte Vandenbussche
Director
since 2019
Establishments
Establishment units
Physical locations of this company
Heestertstraat 39
8540 Deerlijk
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0719.758.212
- VAT number
- BE 0719.758.212
- Registered office
- Heestertstraat 39, 8540 Deerlijk
- Names & denominations
- CURISPHAR
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 February 2019
- Peppol
- Active · Active since 18 Sept 2025
- Activities · NACE
Overige zakelijke dienstverlening, neg